Skip to content
Governance Register

← US public companies

Indevus Pharmaceuticals INC

SEC CIK 854222 · IDEV · last insider filing 2009-03-23

Directors (from insider filings)

NameCapacity as filedFilings
Wysenski Nancy Director filed 2009 - 2009
Gergel Ivan P. Director filed 2009 - 2009
Holveck David Director filed 2009 - 2009
Cooper Glenn L MD Director · President and CEO filed 2006 - 2009
Morley Cheryl P Director filed 2006 - 2009
Mccluski Stephen C Director filed 2006 - 2009
Ferrara Andrew J Director filed 2006 - 2009
Hanson Michael E Director filed 2006 - 2009
Morville Malcolm Director filed 2006 - 2009
Gale James C Director filed 2007 - 2009
Sharrock David B Director filed 2006 - 2007

Officers (from insider filings)

NameTitle as filedFilings
Sandage Bobby W. JR., PHD. Executive Vice President filed 2006 - 2009
Rogers Michael W Executive Vice President filed 2006 - 2009
Butler Mark S Executive Vice President filed 2006 - 2009
Beerman Noah D Executive Vice President filed 2006 - 2009
Ritter Dale Senior Vice President, Finance filed 2006 - 2008
Farb Thomas F President filed 2006 - 2007
Tucker John H EVP, Chief Marketing Officer filed 2006 - 2006

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.